BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Fish and Richardson
Accenture
Express Scripts
QuintilesIMS
Cantor Fitzgerald
Healthtrust
Novartis
Deloitte
Teva

Generated: January 21, 2018

DrugPatentWatch Database Preview

Hydroxocobalamin - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydroxocobalamin and what is the scope of hydroxocobalamin patent protection?

Hydroxocobalamin
is the generic ingredient in four branded drugs marketed by Merck, Serb Sa, Abraxis Pharm, Actavis Llc, Watson Labs, and Bel Mar, and is included in six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Hydroxocobalamin has thirteen patent family members in nine countries.

There are four drug master file entries for hydroxocobalamin. Two suppliers are listed for this compound.
Summary for hydroxocobalamin
Pharmacology for hydroxocobalamin
Drug ClassAntidote
Medical Subject Heading (MeSH) Categories for hydroxocobalamin

US Patents and Regulatory Information for hydroxocobalamin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck ALPHAREDISOL hydroxocobalamin INJECTABLE;INJECTION 080778-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bel Mar HYDROXOMIN hydroxocobalamin INJECTABLE;INJECTION 084629-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abraxis Pharm HYDROXOCOBALAMIN hydroxocobalamin INJECTABLE;INJECTION 084921-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Serb Sa CYANOKIT hydroxocobalamin INJECTABLE;INJECTION 022041-002 Dec 15, 2006 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Watson Labs HYDROXOCOBALAMIN hydroxocobalamin INJECTABLE;INJECTION 085528-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Serb Sa CYANOKIT hydroxocobalamin INJECTABLE;INJECTION 022041-001 Apr 8, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Actavis Llc HYDROXOCOBALAMIN hydroxocobalamin INJECTABLE;INJECTION 085998-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for hydroxocobalamin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Serb Sa CYANOKIT hydroxocobalamin INJECTABLE;INJECTION 022041-002 Dec 15, 2006 ➤ Subscribe ➤ Subscribe
Serb Sa CYANOKIT hydroxocobalamin INJECTABLE;INJECTION 022041-001 Apr 8, 2011 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for hydroxocobalamin

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
QuintilesIMS
Chubb
Citi
Healthtrust
Argus Health
Harvard Business School
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot